Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CNS Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00428090
What this trial is testing

Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 862
Not applicableStudy completedNCT04919993
What this trial is testing

CBT for Insomnia in Primary Brain Tumor Patients

Who this might be right for
Primary Brain TumorPBT
Virginia Commonwealth University 44
Not applicableStudy completedNCT07239102
What this trial is testing

Firmonertinib in the Treatment of EGFR(+) NSCLC Patients With Central Nervous System Metastasis

Who this might be right for
EGFR Positive Non-small Cell Lung CancerCentral Nervous System MetastasisLeptomeningeal Metastasis
Beijing Tiantan Hospital 300
Testing effectiveness (Phase 2)UnknownNCT01567202
What this trial is testing

Study of DC Vaccination Against Glioblastoma

Who this might be right for
GliomaGlioblastoma MultiformeNeoplasms
Huashan Hospital 100
Not applicableWithdrawnNCT05247749
What this trial is testing

CONVIVO System to Discriminate Healthy Tissues vs Tumor Tissues During Brain Tumor Resection

Who this might be right for
Brain Tumor
Stanford University
Not applicableLooking for participantsNCT07278440
What this trial is testing

An Exercise Intervention for Improving Mental and Physical Health in Patients With Primary Brain Tumors and Their Caregivers, ET-NEURO Trial

Who this might be right for
Primary Brain Neoplasm
OHSU Knight Cancer Institute 36
Testing effectiveness (Phase 2)Study completedNCT03936426
What this trial is testing

Peptide Receptor Radionuclide Therapy Administered to Participants With Meningioma With 67Cu-SARTATE™

Who this might be right for
Meningioma
Clarity Pharmaceuticals Ltd 5
Testing effectiveness (Phase 2)Looking for participantsNCT06822543
What this trial is testing

A Single Arm, Phase 2 Study of Datopotamab Deruxtecan, Carboplatin, and Pembrolizumab for Treatment-naive Brain Metastases From NSCLC (Non-small Cell Lung Cancer)

Who this might be right for
Lung CancerNon Small Cell Lung CancerBrain Metastases
Latin American Cooperative Oncology Group 46
Early research (Phase 1)Ended earlyNCT01204450
What this trial is testing

Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastomaSarcoma+1 more
UNC Lineberger Comprehensive Cancer Center 7
Very early researchLooking for participantsNCT05423210
What this trial is testing

Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Stony Brook University 12
Testing effectiveness (Phase 2)Looking for participantsNCT05222620
What this trial is testing

SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial

Who this might be right for
Metastatic Malignant Neoplasm in the BrainMetastatic Malignant Solid Neoplasm
Mayo Clinic 90
Testing effectiveness (Phase 2)Looking for participantsNCT07685938
What this trial is testing

Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease

Who this might be right for
Chest Wall TumorBreast CancerLung Cancer+6 more
UNC Lineberger Comprehensive Cancer Center 60
Not applicableUnknownNCT05106725
What this trial is testing

Wearable Devices and Biomarkers Project (Healthiomics)

Who this might be right for
Brain CancerNeurological DisorderNeurological Cancer
CureScience 3,500
Early research (Phase 1)Ended earlyNCT03332589
What this trial is testing

E6201 Plus Dabrafenib for the Treatment of Metastatic Melanoma Central Nervous System Metastases (CNS)

Who this might be right for
Malignant MelanomaBrain Metastases
Spirita Oncology, LLC 4
Early research (Phase 1)Active Not RecruitingNCT05034497
What this trial is testing

Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases

Who this might be right for
Leptomeningeal Metastasis
Cerenome 18
Testing effectiveness (Phase 2)Looking for participantsNCT04197297
What this trial is testing

Brain Imaging Biomarkers in Patients With Brain Metastasis

Who this might be right for
Brain Metastases, Adult
University Health Network, Toronto 90
Not applicableStudy completedNCT02391493
What this trial is testing

Neural Correlates of Language Control in Bilinguals. Functional MRI and Stimulation Mapping Data in Awake Surgery.

Who this might be right for
Bilingualism
University Hospital, Toulouse 24
Not applicableStudy completedNCT02530749
What this trial is testing

Frailty as a Predictor of Neurosurgical Outcomes in Brain Tumor Patients

Who this might be right for
Brain Tumors
University of Colorado, Denver 265
Large-scale testing (Phase 3)Study completedNCT02350738
What this trial is testing

Effects of Multimodal Cognitive Enhancement Therapy (MCET) for Ealy Dementia

Who this might be right for
Mild Cognitive ImpairmentDementia, Mild
Ki Woong Kim 64
Early research (Phase 1)Study completedNCT03493932
What this trial is testing

Cytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint Blockade

Who this might be right for
Glioblastoma
National Institute of Neurological Disorders and Stroke (NINDS) 21
Next Page